Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Pipeline / planning |
| Buyer: | University of Hertfordshire Higher Education Corporation |
| Main Category: | Services |
| Procurement Method: | — |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
4 December 2025
Closed
Estimated Value
£16,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £16,000 |
| Estimated Value (inc. VAT): | £20,000 |
| Release Date: | 4 November 2025 |
| Application Deadline: | 4 December 2025 |
| Contract Start Date: | — |
| Contract End Date: | 28 February 2026 |
| Contract Duration: | NaN years |
| Procurement ID (OCID): | ocds-h6vhtk-05d9a6 |
| Notice Reference: | 070732-2025 |
All 2 notices for this procurement, oldest first.
CTU Market Analysis
CTU Market Analysis
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £16,000 |
| Award decision date: | — |
| Award status: | Active |
The University of Hertfordshire (UH) is home to the Clinical Trials Support Network (CTSN), which has been operating since 2018 and is now seeking to transition into a fully registered Clinical Trials Unit (CTU) under the UK Clinical Research Collaboration (UKCRC). The CTSN has developed a strong reputation for supporting complex intervention trials, particularly in non-traditional and non-NHS settings, such as public health and social care. Unlike many CTUs that focus on pharmaceutical or chemical trials, CTSN's niche lies in non-chemical, psychosocial, and behavioural intervention research. However, CTSN also supports Phase IV trials involving investigational medicinal products (CTIMPs), especially those focused on real-world effectiveness and safety. This broader remit allows CTSN to contribute to a wider range of clinical research, including studies that bridge traditional and non-traditional trial methodologies. To support strategic planning, investment, and positioning of the CTSN as a nationally recognised CTU, UH is commissioning a comprehensive market analysis.
Published contracts in the last 12 months
8
total contracts
£716k
total value
£238,667
average contract size
Typical categories